Issue of shares pursuant to the 2018 dividend

Syncona Limited - Issue of shares pursuant to the 2018 dividend

PR Newswire

London, July 25

Syncona Limited

Issue of shares pursuant to the 2018 dividend

25 July 2018

Syncona Limited (the "Company") today announces that a total of 1,249,383 new ordinary shares will be issued in satisfaction of the payment of the Company’s 2018 dividend to those qualifying shareholders who did not elect to receive the dividend in cash. The new ordinary shares, when issued, will rank pari passu with the existing issued ordinary shares of the Company.

Application has been made to the Financial Conduct Authority for the shares to be admitted to the Official List, and to the London Stock Exchange for the shares to be admitted to trading and it is expected that dealings will commence in the new ordinary shares on 30 July 2018.

[ENDS]

Enquiries

Syncona LtdAnnabel ClayTel: +44 (0) 20 7611 2010

Northern Trust International Fund Administration Services (Guernsey) LimitedCompany SecretaryTel: 01481 745001

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of genetic medicine, particularly gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.